Companies›Fast Moving Consumer Goods›Fast Moving Consumer Goods›Personal Products

Ravelcare Limited

Fast Moving Consumer Goods › Personal Products
₹84.80
at close · 27 Oct 2026
▼ 3.15 (-3.58%)

Latest filings

  1. Routine RTA certificate - no demat or remat requests in Q2 FY27 · Compliance
  2. Trading Window Closure from October 1, 2026 for Half-Yearly Results · Compliance
  3. Ravelcare 8th AGM: All 4 resolutions passed with 100% approval · Compliance
All filings ↓
Ask Nexa about Ravelcare Limited

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates in the personal care products segment and was listed on BSE in late 2025. FY26 revenue was ₹26.95 crore against total assets of ₹37.63 crore. The company raised capital through an IPO earmarked primarily for a manufacturing facility in Amravati and for marketing, but only a small share of proceeds had been deployed by March 31, 2026. The Amravati plant has not been started, with the allocated capital still parked in bank deposits. The cost structure is dominated by other operating expenses, which run at 47.2% of revenue, with employee costs at 3.8% and reported materials cost at 0%. The company carries no debt, while trade receivables expanded sharply year-on-year.

Operating scale
IPO proceeds raised
₹2,410.20 lakhsFY26
IPO funds utilised
₹760.91 lakhs (31.6%)As of March 31, 2026
Amravati manufacturing facility funds parked
₹780.60 lakhs in Kotak Bank term depositsAs of March 31, 2026
Marketing deployment
₹346.80 lakhs of ₹1,150 lakhs allocated (30%)As of March 31, 2026
Trade receivables
Rose from ₹247.66 lakh to ₹7,105.61 lakhFY26 vs prior year
BSE listing
December 8, 2025 (Scrip Code 544629)
Biggest cost
Other operating expenses at 47.2% of revenue; reported materials cost is 0% of revenue
Kind of business
Recently listed personal care products company; capital-light currently, with planned manufacturing facility not yet set up and zero debt
Where it sits
Small personal care products company listed on BSE (FY26 revenue ₹26.95 crore)
Market Cap
₹58 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
18.9%▲
ROCE (FY26)
ROE — · margin —
Leverage
—·
Debt / Equity · borrowings not filed
Moves on a normal day
2.16%·
Median daily move
Last 197 sessions · the yardstick for filing-day moves
Where it sits among 15 Personal Care peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#4/15
ROCE#10/16

Scorecard

Measured from the filed financials, judged against its Personal Care peers · as of FY26 — not investment advice

Not enough history to assess.

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from Ravelcare Limited's filed financials and exchange disclosures

What does Ravelcare Limited do?

Ravelcare Limited is a Personal Products company listed on BSE.

How much does the Ravelcare Limited share price move in a day?

On a typical session Ravelcare Limited moves 2.16% — that is the median absolute close-to-close move across its last 197 trading days. MarketPing measures each filing's price reaction against it.

Where can I track Ravelcare Limited's announcements?

Every NSE and BSE filing by Ravelcare Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.